Reliance to hive off O2C business, expects approvals by September quarter

The Mukesh Ambani-controlled company had initiated the process to hive off its oil-to-chemicals business at a time when the Covid-19 pandemic caused a slump in fuel demand

Premium

Photo: Reuters

Mumbai

1 min read Last Updated : Feb 23 2021 | 8:51 AM IST

Mukesh Ambani-controlled Reliance Industries Ltd (RIL) expects to get the necessary approvals to hive off its oil-to-chemicals (O2C) business into a separate unit by the second quarter of the next

Topics : Reliance Industries RIL Mukesh Ambani oil

First Published: Feb 23 2021 | 8:42 AM IST

Explore News

Stock Market Updates World Heart Day 2023 Asian Games 2023 Kabaddi schedule Latest News Live Asian Games LIVE updates India Cricket World Cup Squad Hookah Ban in Haryana Gold-Silver Price MCX Share Price Asian Games 2023 September 30 schedule

Companies News

Air India completes acquisition of its 1st A350 aircraft through GIFT City Jalan Kalrock Consortium infuses Rs 100 crore in cash-strapped Jet Airways

Sports News

Asian Games 2023 September 30 schedule: India event timings, streaming Asian Games Day 6 Highlights: Historic shot put medal push IND tally to 33

India News

Punjab farmers continue three-day 'rail roko' agitation over MSP demand War in Ukraine pushes India to obtain more self-propelled guns to arsenal

Economy News

Adani partnership remains steadfast: IHC on Adani units' stake sale Sugar market eyes restrictions from India after lower monsoon rains

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Continue

Reliance to hive off O2C business, expects approvals by September quarter

The Mukesh Ambani-controlled company had initiated the process to hive off its oil-to-chemicals business at a time when the Covid-19 pandemic caused a slump in fuel demand

Also Read

Reliance says India will fully shift to renewable energy in few decades

RIL may remain underperformer for now amid lack of fresh triggers

Shares of Reliance Industries plunge 6% on disclosure concerns

Subdued Q3, few near term triggers to keep RIL stock under pressure

Reliance Industries Q3 consolidated PAT at Rs 13,101 cr, up 12.5% YoY

Top headlines: New corporate pay structure, mapping deregulation, and more

Why deregulation of map-making is a big deal for the corporate sector

India Inc figures out new salary structures to meet labour codes

Can re-engineer Covaxin to beat South African variant: Bharat Biotech

Bharat Biotech to have phase 3 efficacy data for Covaxin in 2 weeks

Explore News